HRT Financial’s PaxMedica, Inc. Common Stock PXMD Stock Holding History

HRT Financial’s Portfolio PXMD Stock Details PXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-634	Closed	-$3K	–	3355
2023 Q3	$3K	Sell	634 -894	-59%	-$8.65K	﹤0.01%	2233
2023 Q2	$20K	Buy	+1,528	New	+$37.5K	﹤0.01%	2102

Other funds holding PXMD

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HRT Financial's PXMD Position: Q4 2023 in Review

HRT Financial sold out of PaxMedica, Inc. Common Stock (PXMD) in Q4 2023, closing a stake of 634 shares — an estimated $3K sold.

HRT Financial first reported a position in PXMD in Q2 2023 and held it in 2 quarters. The position peaked at $20K in Q2 2023. 9 funds tracked by Wall St. Rank hold PXMD as of Q4 2023.

HRT Financial reported no remaining PaxMedica, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
HRT Financial sold 634 PaxMedica, Inc. Common Stock shares in Q4 2023, an estimated $3K.
HRT Financial first reported a position in PaxMedica, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
HRT Financial's PaxMedica, Inc. Common Stock position peaked at $20K in Q2 2023.
9 funds tracked by Wall St. Rank held PaxMedica, Inc. Common Stock as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.